Roles of NF-κB in Cancer and Their Therapeutic Approaches / / edited by Véronique Baud.

Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broad...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018.
Year of Publication:2018
Language:English
Physical Description:1 online resource (x, 330 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603259104498
ctrlnum (CKB)5400000000000203
(NjHacI)995400000000000203
(EXLCZ)995400000000000203
collection bib_alma
record_format marc
spelling Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2018.
1 online resource (x, 330 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research.
Transcription factors.
Proteins Therapeutic use.
Baud, Véronique, editor.
language English
format eBook
author2 Baud, Véronique,
author_facet Baud, Véronique,
author2_variant v b vb
author2_role TeilnehmendeR
title Roles of NF-κB in Cancer and Their Therapeutic Approaches /
spellingShingle Roles of NF-κB in Cancer and Their Therapeutic Approaches /
title_full Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud.
title_fullStr Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud.
title_full_unstemmed Roles of NF-κB in Cancer and Their Therapeutic Approaches / edited by Véronique Baud.
title_auth Roles of NF-κB in Cancer and Their Therapeutic Approaches /
title_new Roles of NF-κB in Cancer and Their Therapeutic Approaches /
title_sort roles of nf-κb in cancer and their therapeutic approaches /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2018
physical 1 online resource (x, 330 pages)
isbn 3-03897-118-9
callnumber-first Q - Science
callnumber-subject QP - Physiology
callnumber-label QP552
callnumber-sort QP 3552 T68 R654 42018
illustrated Not Illustrated
dewey-hundreds 500 - Science
dewey-tens 570 - Life sciences; biology
dewey-ones 572 - Biochemistry
dewey-full 572.8845
dewey-sort 3572.8845
dewey-raw 572.8845
dewey-search 572.8845
work_keys_str_mv AT baudveronique rolesofnfkbincancerandtheirtherapeuticapproaches
status_str n
ids_txt_mv (CKB)5400000000000203
(NjHacI)995400000000000203
(EXLCZ)995400000000000203
carrierType_str_mv cr
is_hierarchy_title Roles of NF-κB in Cancer and Their Therapeutic Approaches /
author2_original_writing_str_mv noLinkedField
_version_ 1796653202253283328
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02502nam a2200289 i 4500</leader><controlfield tag="001">993603259104498</controlfield><controlfield tag="005">20230702121208.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230702s2018 sz o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03897-118-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000000203</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000000203</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000000203</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QP552.T68</subfield><subfield code="b">.R654 2018</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">572.8845</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Roles of NF-κB in Cancer and Their Therapeutic Approaches /</subfield><subfield code="c">edited by Véronique Baud.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (x, 330 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although mortality rates have declined in recent years, the majority of cancers are still difficult to treat and the medical need for better cancer treatment is evident. The current anticancer armamentarium includes many active agents that are applied across tumor types. However, most of these broadly-active anticancer drugs have a small therapeutic index and barely discriminate between malignant and normal cells. In recent years the focus has shifted to the development of rationally designed, molecularly-targeted therapy for the treatment of a specific cancer, therefore offering the promise of greater specificity coupled with reduced systemic toxicity. NF-kB transcription factor family as emerged as such a promising target for cancer therapy. This Special Issue will explore the routes from NF-kB basic research, cancer research and oncogenomics into the development of NF-kB-based cancer therapeutics and biomarkers. We invite research and review papers in any area of the NF-kB field that are related, but not limited to, fundamental understanding of NF-kB signaling pathways, gene expression profiling, epigenetic regulation, diagnostic, prognostic and pharmacogenomic biomarkers, molecular targets driving the progression of human cancers, cancer drug development on these targets, clinical trial with new agents, and validation in animal models. We hope that this Special Issue reflects the exciting era that we are living in with respect to the field of NF-kB and its applications in cancer research.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Transcription factors.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Proteins</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baud, Véronique,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:18:29 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-10-31 22:37:04 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5345719570004498&amp;Force_direct=true</subfield><subfield code="Z">5345719570004498</subfield><subfield code="b">Available</subfield><subfield code="8">5345719570004498</subfield></datafield></record></collection>